Target Price | DKK150.00 |
Price | DKK170.60 |
Deviation |
12.08%
register free of charge
|
Number of Estimates | 2 |
2 Analysts have issued a price target Cbrain 2026 .
The average Cbrain target price is DKK150.00.
This is
12.08%
register free of charge
DKK150.00
12.08%
register free of charge
DKK150.00
12.08%
register free of charge
|
|
A rating was issued by 2 analysts: 0 Analysts recommend Cbrain to buy, 2 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Cbrain stock has an average upside potential 2026 of
12.08%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million DKK | 267.78 | 316.31 |
11.96% | 18.12% | |
EBITDA Margin | 42.24% | 36.94% |
5.21% | 12.54% | |
Net Margin | 24.18% | 22.54% |
8.47% | 6.77% |
2 Analysts have issued a sales forecast Cbrain 2025 . The average Cbrain sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an Cbrain EBITDA forecast 2025. The average Cbrain EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
2 Cbrain Analysts have issued a net profit forecast 2025. The average Cbrain net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share DKK | 3.31 | 3.65 |
2.48% | 10.27% | |
P/E | 45.49 | |
EV/Sales | 10.35 |
2 Analysts have issued a Cbrain forecast for earnings per share. The average Cbrain EPS is
This results in the following potential growth metrics and future valuations:
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.